TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $7,927,000 | -14.9% | 119,324 | 0.0% | 0.26% | -15.8% |
| Q2 2021 | $9,310,000 | -17.5% | 119,324 | 0.0% | 0.30% | -21.9% |
| Q1 2021 | $11,287,000 | -22.4% | 119,324 | 0.0% | 0.39% | -24.1% |
| Q4 2020 | $14,540,000 | +2831.5% | 119,324 | +2001.9% | 0.51% | +2589.5% |
| Q3 2020 | $496,000 | +35.1% | 5,677 | 0.0% | 0.02% | +35.7% |
| Q2 2020 | $367,000 | +44.5% | 5,677 | 0.0% | 0.01% | +27.3% |
| Q1 2020 | $254,000 | -28.2% | 5,677 | 0.0% | 0.01% | -15.4% |
| Q4 2019 | $354,000 | – | 5,677 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |